Download PDF
Hamostaseologie 2008; 28(05): 320-334
DOI: 10.1055/s-0037-1617180
Hämostaseologie
Schattauer GmbH

Gerinnungsdiagnostik

Diagnostic of blood coagulation
M. Barthels
1   Abteilung Hämatologie und Onkologie (Leiter Prof. Dr. med. A. Ganser), Zentrum Innere Medizin und Dermatologie, Medizinische Hochschule Hannover
› Author Affiliations
Further Information

Publication History

Publication Date:
29 December 2017 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Ein Überblick über Besonderheiten, die bei gerinnungs - analytischen Untersuchungen zu beachten sind, wird ge - geben. Sie betreffen die Präanalytik, den analytischen Teil und die Postanalytik. Die gebräuchlichen Gerinnungstests werden behandelt.

Summary

A survey is given on the peculiar characteristics of laboratory methods for analyzing the blood coagulation system with special regard to the preanalytical, analytical and postanalytical phase. Routinely used methods are described.

Schlüsselwörter

Gerinnungsdiagnostik - Labormethoden

Keywords

Blood coagulation diagnostics - laboratory methods
 

  • References

  • 1 Averdunk R, Grüner J. Einfluß von Vorstufen von Faktor II oder Faktor X auf den Quick-Wert bei Verwendung von Thromboplastinen verschiedener Hersteller. J Clin Chem Clin Biochem 1981; 19: 89-97.
    PubMedGoogle Scholar
  • 2 Barthels M. Screening-Methoden in der Hämostase. Hämostaseologie 1999; 19: 146-152.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Barthels M, Depka M. Gerinnungskompendium. Stuttgart: Thieme; 2002
    Google Scholar
  • 4 Bauer KA, Weitz JI. Laboratory markers of coagulation and fibrinolysis. In: Colman RW, Hirsh J, Marder VJ. et al (eds). Hemostasis and thrombosis. Philadelphia: Lippincott Williams & Wilkins; 2001: 1113-1129.
    Google Scholar
  • 5 Bergmann F, Hempel M. Klinik und Diagnostik des Antiphospholipid-Sndroms. Hämostaseologie 2008; 28: 141-149.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Bockenstedt PL. Laboratory methods in hemostasis. In: Loscalzo J, Schafer AIA. (eds). Thrombosis and Hemorrhage. Philadelphia: Lippincott Williams & Williams; 2003: 363-423.
    Google Scholar
  • 7 Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1995; 74: 1185-1190.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Bruhn HD, Schambeck CM, Hach-Wunderle V. (Hrsg). Hämostaseologie für die Praxis. Stuttgart: Schattauer; 2007
    Google Scholar
  • 9 Budde U. Diagnose von Funktionsstörungen der Thrombozyten mit Hilfe der Aggregometrie. J Lab Med 2002; 26: 564-571.
    PubMedGoogle Scholar
  • 10 Bütttner J. The need for accuracy in laboratory medicine. Eur J Clin Chem Clin Biochem 1995; 33: 981-988.
    PubMedGoogle Scholar
  • 11 Büttner J. Diagnostik validity as a theoretical concept and as a measurable quantity. Eur J Clin Chem Clin Biochem 1995; 33: A104-A105.
    PubMedGoogle Scholar
  • 12 Bundesärztekammer.. Richtlinie der Bundesärztekammer zur Qualitätssicherung laboratoriumsmedizinischer Untersuchungen. Deutsches Ärzteblatt 2008; 105: A341-355.
    PubMedGoogle Scholar
  • 13 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haemat (Basel) 1957; 237-246.
    PubMedGoogle Scholar
  • 14 Colman RW, Marder VJ. Clowes et al (eds). Hemostasis and Thrombosis. Basic principles and clinical practice. 5th ed. Philadelphia: Lippincott, Williams & Williams; 2006
    Google Scholar
  • 15 Committee of the International Society on Thrombosis and Haemostasis (ISTH/SSC) and the Commission/ Committee on Qualities and Units in Clinical Chemistry of the International Union of Pure and Applied chemistry – International Federation of clinical chemistry (IUPAC-IFCC/CQU (CC).. Nomenclature and units in thrombosis and haemostasis. Thromb Haemost 1994; 71: 375-394.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Dehmel H, Werwitzke S, Trummer A. et al. Thromb elastographic moinitoring of recombinant factor VIIa in acquired haemophilia. Haemophilia 2008; 14: 736-742.
    PubMedGoogle Scholar
  • 17 Dempfle CE, Zips S, Ergül H. et al. The fibrin assay comparison trial (FACT). Thromb Haemost 2001; 85: 671-678.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 DIN EN ESO 15189, Beuth-Verlag 2007.
    PubMed
  • 19 DIN-Taschenbuch 261.. Hämostaseologie. Berlin, Wien, Zürich: Beuth; 2002
    Google Scholar
  • 20 DIN-Taschenbuch 261.. Hämostaseologie Normen. E 58 905-1. Hämostaseologie – Blutent - nahme. Teil 1: Gewinnung von venösem Citratplasma für hämostaseologische Analysen. Berlin, Wien, Zürich: Beuth; 2002: 19-22.
    Google Scholar
  • 21 DIN-Taschenbuch 261.. Hämostaseologie Normen. E 58 906-1. Hämostaseologie – Bestimmung der Fibrinogenkonzentration. Teil 1: Referenzmeßverfahren für die Bestimmung des gerinnbaren Fibrinogens nach Clauss. Berlin, Wien, Zürich: Beuth; 2002: 23-27.
    Google Scholar
  • 22 DIN-Taschenbuch 261.. Hämostaseologie Normen. E 58 910–1–4. Hämostaseologie – Thromboplastinzeitbestimmungen. Berlin, Wien, Zürich: Beuth; 2002: 47-62.
    Google Scholar
  • 23 DIN-Taschenbuch 261.. Hämostaseologie Normen. E 58 939–1. Hämostaseologie – Referenzplasma: Teil 1: Anforderungen, Herstellung. Berlin, Wien, Zürich: Beuth; 2002: 19-22.
    Google Scholar
  • 24 Domsch Ch, Müller-Beißenhirtz H, Spannagl M. Einsatz des PFA-100 bei angeborenen und erworbenen hämorrhagischen Diathesen. Hämostaseologie 1999; 19: 176-181.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Fairweather RB, Ansell J, van den Besselaar AMHP. et al. College of American pathologists conference XXXI on laboratory monitoring of anticoagulant therapy. Arch Pathol Lab Med 1998; 122: 768-781.
    PubMedGoogle Scholar
  • 26 Gram J, Jespersen J. Introduction to laboratory assays in haemostasis and thrombosis. In: Jespersen J, Bertina RM, Haverkate F. (eds). Laboratory techniques in thrombosis. A Manual. 2nd revised edition of ECAT assay procedures. Dordrecht, Boston, London: Kluwer Academic Publishers; 1999: 1-8.
    Google Scholar
  • 27 Hartert H. Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin Wschr 1948; 26: 577-583.
    CrossrefPubMedGoogle Scholar
  • 28 Hayward CPM, Harrison P, Cattaneo M. et al. Platelet function analyzer (PFA)-100® closure time in the evaluation of platelet disorders and platelet function. Working group on the PFA-100®, ISTH-SSC platelet physiology subcommittee. J Thromb Hemost 2006; 4: 312-319.
    CrossrefPubMedGoogle Scholar
  • 29 Hemker HC, Kessels H. Feedback mechanisms in coagulation. Haemostasis 1991; 21: 189-196.
    PubMedGoogle Scholar
  • 30 Hemker HC, Al Dieri R, de Smedt E, Béguin S. Thormbin generation, a function test of the haemostatic thrombotic system. Thromb Haemost 2006; 96: 553-561.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Jespersen J, Bertina RM, Haverkate F. (eds). Laboratory Techniques in Thrombosis – A Manual. ECAT Assay Procedures. Heidelberg: Springer; 2007
    Google Scholar
  • 32 Jürgens J. Über das Verhalten antithrombotischer Substanzen bei Erkrankungen der Leber. Dtsch Arch Klin Med 1952; 200: 67-85.
    PubMedGoogle Scholar
  • 33 Kang J. Thrombelastography in liver transplantation. Semin Thromb Hemost 1995; 21: 34-44.
    PubMedGoogle Scholar
  • 34 Kapiotis S, Speiser W, Pabinger-Fasching I. et al. Anticardiolipin antibodies in patients with venous thrombosis. Haemostasis 1991; 21: 19-24.
    PubMedGoogle Scholar
  • 35 Kitchens CS. To bleed or not to bleed?. Is that the question for the PTT? J Thromb Hemost 2005; 3: 2607-2611.
    PubMedGoogle Scholar
  • 36 Köhler M, Dati F, Kolde HJ. Aktivierte partielle Thromboplastinzeit(aPTT)-Standortbestimmung – Standardisierung der Methode, Interpretation der Befunde und Grenzen der Anwendbarkeit. Lab Med 1995; 19: 162-166.
    PubMedGoogle Scholar
  • 37 Korte W. Perioperative Gerinnungsstörungen, peri operatives Gerinnungsmanagement. Hämostaseologie 2008; 28: 449-454.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 38 Koscielny J, von Tempelhoff GF, Ziemer S. et al. A practical concept for preoperative management of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 2004; 10: 155-166.
    CrossrefPubMedGoogle Scholar
  • 39 Lechner K. Blutgerinnungsstörungen. Berlin, Heidelberg, New York: Springer; 1982: 235-266.
    Google Scholar
  • 40 Lindhoff-Last E, Bauersachs R, Funke U. et al. Die Beeinflussung von Gerinnungstesten durch rekombinantes Hirudin. J Lab Med 2000; 24: 407-413.
    PubMedGoogle Scholar
  • 41 Mannhalter C. Molekularbiologie und Hämostase. Hämostaseologie 2008; 28: 272-288.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 42 Mannucci PM, Canciani MT, Mari D. et al. The varied sensitivity of partial thromboplastin reagents in the demonstration of the lupus-like anticoagulant. Scand J Haematol 1979; 22: 423-432.
    PubMedGoogle Scholar
  • 43 Miyakis S, Lockshin MD, Atsumi T. et al. Inter - national consensus statement on an update of the classification criteria for definite antiphospho - lipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
    CrossrefPubMedGoogle Scholar
  • 44 Müller-Berghaus G, Barthels M, Pötzsch B. 7.3 Checkliste Klinische Chemie und Hämatologie – Hämostaseologische Untersuchungen. In: Medizinisches Labor.. Qualitätsmanagement und Akkreditierung Band 1 und 2. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2002
    Google Scholar
  • 45 Müller-Beißenhirtz W, Deickert F, Lang H. et al. Selbstkontrolle der oralen Antikoagulation: Standortbestimmung. J Lab Med 1997; 21: 558-562.
    PubMedGoogle Scholar
  • 46 NCCLS document H21-A3.. Collection, transport and preparation of blood specimens for coagulation testing and performance of coagulation assays: Approved guideline. Villanova PA: National Committee for Clinical Laboratory Standards:; 1991
    Google Scholar
  • 47 Oldenburg J, Barthels M. Angeborene Koagulopathien am Beispiel der Hämophilie A und B, Hemmkörperhämophilie. Hämostaseologie 2008; 28: 335-347.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 48 Owren PA. Parahaemophilia, haemorrhagic diathesis due to absence of a previously un-known clotting factor. Lancet 1947; 1: 446-448.
    PubMedGoogle Scholar
  • 49 Pötzsch B, Madlener K, Seelig C. et al. Monitoring of r-Hirudin anticoagulation during cardiopulmonary bypass – assessment of the whole blood ecarin clotting time. Thromb Haemost 1997; 77: 920-925.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 50 Poller L. Activated partial thromboplastin time (aPTT). In: Jespersen J, Bertina RM, Haverkate F. (eds). Laboratory techniques in thrombosis. A Manual. 2nd revised edition of ECAT assay procedures. Dordrecht, Boston, London: Kluwer Academic Publishers; 1999: 37-44.
    Google Scholar
  • 51 Poller L. Prothrombin time. In: Jespersen J, Bertina RM, Haverkate F. (eds). Laboratory techniques in thrombosis. A Manual. 2nd revised edition of ECAT assay procedures. Dordrecht, Boston, London: Kluwer Academic Publishers; 1999: 45-61.
    Google Scholar
  • 52 Preissner K. Physiologie der Blutgerinnung und Fibrinolyse: Biochemie. Hämostaseologie 2008; 28: 259-271.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 53 Proctor RR, Rapaport SJ. The partial thromboplastin time with kaolin: A simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Path 1961; 36: 212-219.
    CrossrefPubMedGoogle Scholar
  • 54 Quick AJ. The prothrombin in hemophilia and in obstructive jaundice. J Biol Chem 1935; 109: 73-74.
    PubMedGoogle Scholar
  • 55 Riess H. Erworbene Koagulopathien. Hämostaseologie 2008; 28: 348-357.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 56 Righini M, Perrier A, De Moerloose P, Bounameaux H. D-Dimer for venous thromboembolism diagnosis: 20 years later. J Thromb Haemost 2008; 6: 1059-1071.
    CrossrefPubMedGoogle Scholar
  • 57 Roschitz B, Thaler S, Koestenberger M. et al. PFA-100 closure times in preoperative screening in 500 pediatric patients. Thromb Haemost 2007; 98: 243-247.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 58 Rugeri L, Levrat A, David JS. et al. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 2007; 5: 289-295.
    CrossrefPubMedGoogle Scholar
  • 59 Schambeck CM. PFA-100®: Globaltest der primären Hämostase?. J Lab Med 2002; 26: 557-562.
    PubMedGoogle Scholar
  • 60 Scharf RE. Angeborene und erworbene Thrombozytenfunktionsstörungen. Hämostaseologie 2002; 23: 170-180.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 61 Schneppenheim R, Budde U. Angeborenes und erworbenes von-Willebrand-Syndrom. Hämostaseologie 2008; 28: 312-319.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 62 Schwarz UR, Eigenthaler M. Platelet flow cytometry – a new dimension. J Lab Med 2002; 26: 594-599.
    PubMedGoogle Scholar
  • 63 Sheth SB, DiCicco RA, Hursting MJ. et al. Interpreting the International Normalized Ratio (INR) in individuals receiving Argatroban and warfarin. Thromb Haemost 2001; 85: 435-440.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 64 Sibbing D, Braun S, Jawansky S. et al. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb Haemost 2008; 99: 121-126.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 65 Spannagl M, Calatzis A. Point-of-Care Analyse des Hämostasesystems. J Lab Med 2002; 26: 68-76.
    PubMedGoogle Scholar
  • 66 Spitzenberger F, Weidemann G, Hafner G. Akkreditierung von POCT nach ISO 22870 – Anforderungen an Qualität und Kompetenz. J Lab Med 2006; 30: 264-271.
    PubMedGoogle Scholar
  • 67 Symposiumbericht: Endogenes Thrombinpotenzial Leipzig 2007. Hämostaseologie 2007; 27: 220-223.
    PubMedGoogle Scholar
  • 68 Taylor FB, Toh C-H, Hoots WK. et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86: 1327-1330.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 69 Thomas L. Labor und Diagnose. Indikation und Bewertung von Laborbefunden für die medizinische Diagnostik 7. Auflage: 2008. TH-Books.;
    Google Scholar
  • 70 Thóth O, Calatzis A, Penz S. et al. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 2006; 96: 781-788.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 71 Toh CH, Hoots WK. on behalf of the SSC on Disseminated Intravascular Coagulation of the ISTH.. The scoring system of the Scientific and Standardization Committee on Disseminated Intravsacular Coagulation of the International Society on Thrombosis and Haemostasis: a 5 year overview. J Thromb Haemost 2007; 5: 604-606.
    CrossrefPubMedGoogle Scholar
  • 72 Traverso CI, Caprini JA, Arcelus JI. The normal thrombelastogram and its interpretation. Semin Thromb Hemost 1995; 21: 7-13.
    PubMedGoogle Scholar
  • 73 Van Vliet HHDM, Kappers-Klunne M, Leebeek FWG, Michiels JJ. Desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2. Thromb Haemost 2008; 100: 462-468.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 74 Walker ID. Blood collection and sample preparation: preanalytical variation. In: Jespersen J, Bertina RM, Haverkate F. (eds). Laboratory techniques in thrombosis. A Manual. 2nd revised edition of ECAT assay procedures. Dordrecht, Boston, London: Kluwer Academic Publishers; 1999: 21-28.
    Google Scholar
  • 75 WHO Expert Committee on Biological Standardization.. 48th report 1999. WHO technical report series 889. Annex 3. Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy.
    PubMedGoogle Scholar
  • 76 Witt I, Beeser H, Müller-Berghaus G. Minimal - anforderungen zur Gewinnung von Citratplasma für hämostaseologische Analysen. Lab Med 1995; 19: 143-145.
    PubMedGoogle Scholar
  • 77 Witt I, Beeser H, Lang H. et al. Thromboplastinzeit und INR: Standardisierung der Methode, Anwendung zur Kontrolle der oralen Antikoagulantientherapie und als Globaltest der plasmatischen Gerinnung – Standortbestimmung. Lab Med 1996; 20: 443-449.
    PubMedGoogle Scholar
  • 78 Witt I. Testsysteme mit synthetischen Peptid - substraten in der Hämostaseologie. Hämostaseologie 1988; 8: 47-61.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 79 Wuillemin WA. Point of care testing – Vollblut - methoden in der Hämostaseologie. Hämostaseologie 2000; 20: 13-16.
    Article in Thieme ConnectPubMedGoogle Scholar